Perspective Therapeutics, Inc. (CATX) AMEX

3.43

-0.03(-0.87%)

Updated at September 08 04:00PM

Currency In USD

Perspective Therapeutics, Inc.

Address

350 Hills Street

Seattle, WA 99354

United States of America

Phone

509 375 1202

Sector

Healthcare

Industry

Medical - Devices

Employees

138

First IPO Date

November 10, 2005

Key Executives

NameTitlePayYear Born
Mr. Johan M. SpoorChief Executive Officer & Director948,2231972
Mr. Jonathan R. HuntChief Accounting Officer611,1651967
Dr. Markus Puhlmann M.B.A., M.D.Chief Medical Officer702,2431966
Mr. Andrew BrightExecutive Vice President of Brachytherapy0N/A
Mr. Amos Hedt BA, PGradDipChief Business Strategy Officer0N/A
Ms. Annie J. ChengVice President of Investor Relations01976
Mr. Shane CobbExecutive Vice President of Operations0N/A
Dr. Michael K. Schultz Ph.D.Chief Science Officer0N/A
Mr. Chris NennoGeneral Counsel & Corporate Secretary0N/A
Mr. Juan GrahamChief Financial Officer01977

Description

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.